Skip to main content

convolutional neural network

By Dave Muoio | 03:06 pm | November 04, 2020
The tool was "100% accurate" when spotting cases among asymptomatic individuals, the researchers wrote, and could be deployed as a low-cost prescreener to support diagnostic testing efforts.
By Dave Muoio | 12:28 pm | April 18, 2019
The Boston-based company has grown from 25 to 60 staff members within the past year, and has collaborated with pharmaceutical partners such as Bristol-Myers Squibb and Novartis.